Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Piotr Zorga is active.

Publication


Featured researches published by Piotr Zorga.


The Journal of Nuclear Medicine | 2011

Patient-Specific Radiation Dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in Neuroendocrine Tumors

Joshua Grimes; Anna Celler; Bożena Birkenfeld; Sergey Shcherbinin; Maria H. Listewnik; Hanna Piwowarska-Bilska; Renata Mikolajczak; Piotr Zorga

99mTc-hydrazinonicotinamide-Tyr3-octreotide (99mTc-HYNIC-TOC) is increasingly gaining acceptance as a new radiopharmaceutical for the diagnosis of pathologic lesions overexpressing somatostatin receptors. However, little information has been published about the radiation dosimetry of this agent. The aim of this study was to assess the biodistribution and radiation dosimetry of commercially available 99mTc-HYNIC-TOC. A dose calculation procedure designed to be feasible to implement in a busy clinical environment was used. Methods: Twenty-eight patients were imaged for suspected neuroendocrine tumors using a series of whole-body planar, dynamic planar, and SPECT/CT studies, after injection with 99mTc-HYNIC-TOC. Patient-specific dosimetry was performed using the OLINDA/EXM software with time-integrated activity coefficients estimated from a hybrid planar/SPECT technique. A phantom experiment was performed to establish adaptive thresholds for determination of source region volumes and activities. Results: Pathologic uptake, diagnosed as due to neuroendocrine tumors, was observed in 12 patients. Normal organs with significant uptake included the kidneys, liver, and spleen. The mean effective dose after 99mTc-HYNIC-TOC injection was 4.6 ± 1.1 mSv. Average normal-organ doses were 0.030 ± 0.012, 0.021 ± 0.007, and 0.012 ± 0.005 mGy/MBq for the spleen, kidneys, and liver, respectively. The interpatient kidney dose ranged from 0.011 to 0.039 mGy/MBq, whereas the range of tumor doses varied from 0.003 to 0.053 mGy/MBq. The ratio of tumor to kidney dose ranged from 0.13 to 2.9. The optimal thresholds for recovery of true activity in the phantom study were significantly lower than those used for volume determination. Conclusion: The patient-specific 3-dimensional dosimetry protocol used in this study is a clinically feasible technique that has been applied to demonstrate large dose variations in tumors and normal organs between patients imaged with 99mTc-HYNIC-TOC.


Radiation Protection Dosimetry | 2010

Long-term monitoring of radiation exposure of employees in the department of nuclear medicine (Szczecin, Poland) in the years 1991-2007.

Hanna Piwowarska-Bilska; Bożena Birkenfeld; Maria H. Listewnik; Piotr Zorga

Occupational radiation exposure is a hazard that should be avoided or at least minimised. This study aimed to evaluate the radiation exposure of nuclear medicine department employees monitored during the 1991-2007 period, and to investigate the relationship between the annual effective doses of the personnel and the number of radioisotope procedures performed. Overall, 2014 quarterly effective whole-body doses, categorised into six occupational groups, monitored with personal dosemeters, were analysed statistically. There was a wide variation in the average annual doses among the different occupational groups. During the 17 years covered by this study, there was no incidence of a dose exceeding the annual dose limit of 20 mSv. There was a weak correlation between the average annual dose for monitored employees and the number of nuclear medicine procedures performed. Apart from exposure, personal skill in dealing with radioactive substances, compliance with radiation protection rules is an important factor to minimise the effective dose.


Journal of Nuclear Medicine Technology | 2010

Optimization of Low-Dose CT Protocol in Pediatric Nuclear Medicine Imaging

Hanna Piwowarska-Bilska; Leszek J. Hahn; Bożena Birkenfeld; Katarzyna Cichoń-Bańkowska; Maria H. Listewnik; Piotr Zorga

This study was performed to find the optimal low-dose CT protocol for children being imaged on SPECT/CT scanners not equipped with automatic dose control. For SPECT/CT systems with manually adjustable x-ray tube voltage (kV) and anode current (mA), an optimized protocol makes it possible to minimize the dose to patients. Methods: Using the 4-slice low-dose CT component of a commercially available SPECT/CT scanner, we compared the signals reaching the CT detector after radiation passes through objects of different sizes. First, the exit dose rates were measured for combinations of available voltages and currents. Next, imaging parameters were selected on the basis of acceptable levels of exit dose rates, cylindric phantoms of different diameters approximating children of different sizes were scanned using these parameters, and the quality of the CT images was evaluated. Finally, weighted CT dose indexes for abdomen and head CT dose phantoms simulating, respectively, adult and pediatric patients were measured using exactly the same techniques to estimate and compare doses to these 2 groups of patients. Results: For children with torsos smaller than 150 mm, imaging can be performed using the lowest available voltage and current (120 kV and 1 mA, respectively). For children with torsos less than 250 mm, 140 kV and 1.5 mA can be used. For patients with torsos greater than 250 and less than 300 mm, 140 kV and 2 mA can be used. Regarding the signal-to-noise ratio, all these parameters give an excellent signal and fully acceptable noise levels. Conclusion: For the SPECT/CT system studied, even the lowest available voltage and current used for scanning pediatric patients did not cause signal-to-noise degradation, and the use of these settings substantially lowered the dose to the patients.


asian conference on intelligent information and database systems | 2017

The Use of Tuned Shape Window for the Improvement of Scars Imaging in Static Renal Scintigraphy in Children

Janusz Pawel Kowalski; Bożena Birkenfeld; Piotr Zorga; Jakub Peksinski; Grzegorz Mikolajczak

Physiological renal processes are evaluated based on planar images registered by a gamma camera, SPECT or PET. However, detection of small disorders in standard planar scintigraphic imaging is difficult and sometimes impossible. The aim of the research conducted at Pomeranian Medical University is to increase the sensitivity of the method for detecting the areas of renal functional disorders called scarring. The image recorded as a result of the test was subject to digital processing. In that purpose, a novel window function was used for filter designing. Standard and processed images were presented to three independent experts. The diagnosis results were subject to statistical analysis. As a result, a large share of changes in diagnosis was reported in the total number of conducted tests, a strong correlation between positive evaluation of the role of processed images and a change in diagnosis as well as an increased possibility of kidney condition evaluation.


Nuclear Medicine Review | 2012

Prognostic value of myocardial perfusion scintigraphy for patients suspected of and diagnosed with coronary artery disease.

Piotr Zorga; Bożena Birkenfeld; Maria H. Listewnik; Hanna Piwowarska-Bilska

BACKGROUND The prognostic value of myocardial perfusion scintigraphy (MPS) continues to attract interest and provoke discussions.This study was an attempt to investigate the methods. OBJECTIVE Determination of the prognostic value of MPS for patients suspected of and diagnosed with coronary artery disease (CAD). MATERIAL AND METHODS The study group included 215 patients, 134 males and 81 females, aged 21-66, mean age 48. Tc-99m-MIBI myocardial perfusion scintigraphy was performed and information concerning the diagnosis, aim of the examination, past coronary episodes, clinical condition, duration and type of complaints, concomitant diseases, test results, revascularisation procedures and pharmacological treatment was gathered. Further history of the patients was monitored throughout the observation period of 52 months on average. The patients were divided into the following two groups: Group I - suspected coronary artery disease: 124 patients aged 21-65,59 males and 65 females; Group II - diagnosed coronary artery disease: 91 patients aged 31-66, 75 males and 16 females diagnosed with CAD, including 39 s/p myocardial infarct, 31s/p infarct and revascularisation, 21 s/p revascularisation. The probability of CAD was calculated using the Diamond method for the patients suspected of CAD. The obtained results were examined in a statistical analysis. RESULTS Normal MPS results were obtained for 94/124 patients suspected of CAD, 15/91 patients diagnosed with CAD,64/81 females and 45/134 males. In Group I, apart from pathological MPS results, reversible ischemia was determined in as many as 27/30 patients, and only 17/91 patients in Group II. No patients with normal MPS results suffered major cardiac events,only one of them underwent revascularisation. Major cardiac events occurred in the case of patients with pathological MPS results: Group I - 2 myocardial infarcts and 2 cardiac deaths,Group II - 3 infarcts and 10 cardiac deaths. Minor cardiac events, apart from one case, were also only observed in the case of patients with pathological MPS results: Group I - 10 revascularisations and one case of unstable CAD, Group II- 12 revascularisations and 7 cases of unstable CAD. Patients with normal MPS results and stenosis in coronary angioraphy suffered no cardiac events. Cardiac events occur mostly in the group with a medium and high risk of CAD and in the case of patients diagnosed with CAD. CONCLUSIONS 1. Normal MPS results for patients suspected of or diagnosed with CAD: s/p infarct and/or CABG prognosticate a mild course of the disease, without or with a minimal number of cardiac events, also in a longer observation period.2. Pathological MPS results clearly imply a greater risk of cardiac events, and the number of events increases with the greater probability of CAD and with the patients age. 3. Normal MPS results, even with significant stenosis in coronary angiography,prognosticate a low risk of cardiac events.


Pediatria polska | 2008

Ocena wielkości i funkcji nerek u dzieci z ostrą białaczką limfoblastyczną (OBL) po zakończeniu leczenia

Jarosław Peregud-Pogorzelski; Monika Matacz; Andrzej Brodkiewicz; Anna Walecka; Bożena Birkenfeld; Katarzyna Grudzińska; Piotr Zorga

Wstep Nerki są organem szczegolnie narazonym na upośledzenie ich funkcji oraz wystepowanie powiklan w czasie leczenia i po zakonczonym leczeniu ostrej bialaczki limfoblastycznej (OBL), ktore w sposob istotny mogą wplywac na komfort i dlugośc zycia pacjentow. Cel pracy Celem pracy byla ocena wielkości i funkcji nerek u dzieci, oraz określenie czynnikow mających wplyw na wystepowanie nieprawidlowości w ich funkcjonowaniu po zakonczonym leczeniu OBL za pomocą wybranych badan klinicznych, biochemicznych i obrazowych. Material i metody Badaniami objeto grupe 48 dzieci, w tym 29 (60%) chlopcow i 19 (40%) dziewczynek, w wieku 79–275 miesiecy (średnia 159 miesiecy; SD 49 miesiecy), u ktorych w latach 1989–2001 ustalono rozpoznanie OBL. Wyniki i wnioski Wykazano, ze stosowany program chemioterapii i czas obserwacji dluzszy niz 5 lat po zakonczenia leczenia w sposob istotny wplywaly na obnizenie wartości GFR, wystepowanie blizn w nerkach oraz zmniejszenie objetości i dlugości nerek. Dlatego konieczne wydaje sie objecie okresową opieką nefrologiczną pacjentow po zakonczeniu leczenia OBL.


Radiation Protection Dosimetry | 2013

Radiation doses of employees of a Nuclear Medicine Department after implementation of more rigorous radiation protection methods

Hanna Piwowarska-Bilska; Aleksandra Supinska; Maria H. Listewnik; Piotr Zorga; Bożena Birkenfeld


Endokrynologia Polska | 2010

The application of SPECT/CT scintigraphy with MIBI-Tc 99m in the diagnosis of thyroid nodules - a preliminary report

Maria H. Listewnik; Bożena Birkenfeld; Hanna Piwowarska-Bilska; Katarzyna Cichoń-Bańkowska; Lidia Iglińska-Wagner; Wanda Watrak; Wiesława Smolira; Piotr Zorga; Krystyna Niedziałkowska; Bogumiła Elbl; Marek Sawrymowicz


Physica Medica | 2018

[P111] Eye lens exposure to ionising radiation in personnel of a nuclear medicine department.

Hanna Piwowarska-Bilska; Aleksandra Supinska; Piotr Zorga; Bożena Birkenfeld


International Journal of Clinical and Experimental Medical Sciences | 2017

Brain Perfusion Scintigraphy in Evaluation of Pathogenesis of Fatigue in Patients with Primary Biliary Cholangitis (PBC) – A Pilot Study

Joanna Raszeja-Wyszomirska; Piotr Zorga; Marcin Kotulski; Bożena Birkenfeld; Piotr Milkiewicz

Collaboration


Dive into the Piotr Zorga's collaboration.

Top Co-Authors

Avatar

Bożena Birkenfeld

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maria H. Listewnik

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Anna Walecka

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Anna Celler

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Sergey Shcherbinin

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Andrzej Brodkiewicz

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Grzegorz Mikolajczak

West Pomeranian University of Technology

View shared research outputs
Top Co-Authors

Avatar

Jacek Iwanowski

Pomeranian Medical University

View shared research outputs
Top Co-Authors

Avatar

Jakub Peksinski

West Pomeranian University of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge